Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. - Wikidata - awgldk - TriplyDB

Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.

Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.

http://www.wikidata.org/entity/Q27851704

about

Molecular genetics and immunohistochemistry characterization of uncommon and recently described renal cell carcinomas CIViC database Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib.ALK-rearrangements and testing methods in non-small cell lung cancer: a review ALK Fusion Detection in Circulating Free DNA: Finding an Important Needle in the Haystack KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only Comprehensive exploration of novel chimeric transcripts in clear cell renal cell carcinomas using whole transcriptome analysis VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment.Targeting ALK in neuroblastoma--preclinical and clinical advancements.ALK-Positive Renal Cell Carcinoma in a Large Series of Consecutively Resected Korean Renal Cell Carcinoma Patients.ALK gene amplification is associated with poor prognosis in colorectal carcinoma Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.Tyrosine kinase gene rearrangements in epithelial malignancies.Treating ALK-positive lung cancer--early successes and future challenges.Recent classification of renal epithelial tumors.Recent advances of immunohistochemistry for diagnosis of renal tumors.ALK-positive cancer: still a growing entity.Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled meta-analysis.Novel ALK inhibitors in clinical use and development.Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer.ALK-rearranged renal cell carcinomas in children.ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.Targeted inhibition in tumors with ALK dependency.Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review.Targeting ALK: Precision Medicine Takes on Drug Resistance.Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript.Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features.NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases.Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.[Histopathology of renal cell carcinoma].Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases.A case of anaplastic lymphoma kinase-positive renal cell carcinoma coincident with Hodgkin lymphoma.Pulmonary inflammatory myofibroblastic tumor harboring EML4-ALK fusion gene.Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes.[The translocation carcinoma: A pediatric renal tumor also in adults].The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer.

P2860

Q26752945-D5A0FBB2-2450-4EEF-8467-98422300DA57 Q27612411-8BDC3CDB-3C40-4C33-9EC0-95742D3A9693 Q27852211-B4C5E179-D663-49B6-B603-13B6CF7F0893 Q27853092-E533E858-6875-40C8-A312-ADBE4E9814AE Q33776835-D858DB5D-6F65-48AF-B542-B0245A48323E Q33898894-7EE565CD-7B1C-42DB-894B-2D766871873E Q34162787-CA7D136A-1EC1-4154-8349-61DF208BFA20 Q35005701-555141C4-5167-4086-892D-CD80A07919DF Q35155611-A7AC05BE-B896-43AE-A293-569C392ED6BC Q36405628-19511A6C-73BE-4349-B3CE-9B48AE39061C Q36739466-60B22E1B-6FBC-4200-B210-C43670F5FF47 Q36929734-6755FBC0-F3BD-46D1-B4FD-5F86EF0277F0 Q36933081-9FC782B0-B303-42E4-86B0-91D64F90614D Q37316727-FBFB5DA4-951A-4E24-97B3-541BC44DCC36 Q37323062-8F63B5C4-3B66-4C8A-A6BC-0960F4DD388E Q37330688-5870BA7E-6A69-4B85-993C-04D791368A69 Q37515966-48D8CECE-EC2A-47EA-A171-FF1A96F78C23 Q37999657-AFF53D58-8910-43C2-A78D-4DA0D7918AD6 Q38093050-81D0DFEA-D29D-4004-A01D-65D396908190 Q38129966-D264930A-BF09-487C-B231-2D68FD1318C2 Q38184584-75FE1224-C0C7-4734-8FF3-4C1CE8D2B7DC Q38245927-72CF39E9-A810-4A2D-897B-76F9C24AD47A Q38427240-F8173219-28D2-4346-BF4F-8B97EF42A05E Q38459398-D4C678A3-E4C6-4E14-B3E0-86ED70CD06E6 Q38698507-E2A3855B-880D-4FFA-B41E-BCF5871E283A Q38701797-DCFAF8E7-901A-4F57-B73D-A5BAA2459B92 Q38956321-A9DC4DE5-FBEF-419F-9E4F-DC8A281DA95B Q38960212-4F73069F-83B5-4C44-B272-15F6DB42D085 Q39103431-D0ECFD55-BB2D-450A-B115-83B14664C95C Q41642267-6D921ED8-07EE-4C42-8ABD-6C3D8E2CE53F Q41670942-1F3D79B5-9DAA-4321-8B0B-B086B4B3BA87 Q42254184-A8FDE05F-E9DB-46D4-96DB-A1B105DA64DF Q44136116-B584128E-DD53-4D88-A5F4-90980A195BB5 Q44939020-54432EE3-91E3-4B76-8144-F0FA1AC868E0 Q48254756-6CBF599A-0B04-439B-AD73-994BCC7A5D30 Q50099001-796E245B-1E0E-485D-871C-4AF2CAC5EFCD Q50483026-C7031F3D-B7FB-4D70-9EB9-6A2613FD42CA Q52679023-7F71839F-A570-426E-A034-B4B8B7A54C07 Q53149212-7E308D9A-2650-41F0-BE6E-DEC1980F468F Q53607051-4EFAE458-8B90-4C9C-BE79-8FC73666E1DC

P2860

Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.

http://www.wikidata.org/entity/Q27851704

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Identification of anaplastic l ...... ibody-enhanced polymer method.

@ast

Identification of anaplastic l ...... ibody-enhanced polymer method.

@en

Identification of anaplastic l ...... ibody-enhanced polymer method.

@nl

type

label

Identification of anaplastic l ...... ibody-enhanced polymer method.

@ast

Identification of anaplastic l ...... ibody-enhanced polymer method.

@en

Identification of anaplastic l ...... ibody-enhanced polymer method.

@nl

altLabel

Identification of anaplastic l ...... tibody-enhanced polymer method

@en

prefLabel

Identification of anaplastic l ...... ibody-enhanced polymer method.

@ast

Identification of anaplastic l ...... ibody-enhanced polymer method.

@en

Identification of anaplastic l ...... ibody-enhanced polymer method.

@nl

P1433

Q27851704-64259ED8-FEC9-448C-9AC1-F19CCEC82544

P1476

Q27851704-A04F59C5-DF26-4FB4-A1C0-57EB38AD8D02

P2093

Q27851704-0B215F43-7038-438D-BBB6-C306EC360E41

Q27851704-28A31BE8-4B72-4FAB-8838-F1C9C1154F94

Q27851704-31B40B40-F59B-4618-ACB4-396C0C7D5E03

Q27851704-43848CAD-73CB-48F3-B278-2A987D0CACCC

Q27851704-4945E24C-F694-4D03-8BBA-2F4A59F6668B

Q27851704-8C20732F-A44B-4753-8121-706B23A79107

Q27851704-95671AEF-62A8-43C6-8ED3-71B1A18A7EAB

Q27851704-9BD9F9B5-AB31-46A1-BD35-E825E0C20D09

Q27851704-BE135B60-7FCB-4F33-A82A-4D29DB82B1C2

Q27851704-C4F7C8AA-A681-44F4-8B6B-F9A4433D9EDE

P2860

Q27851704-03A9ECBF-E663-4F60-A78A-CF0A1576A97F

Q27851704-04402032-E5FB-49AF-A81D-5FBDBC81E9FE

Q27851704-22BC8E71-DCED-4885-AF28-983BFD162D1F

Q27851704-23B05461-613C-46D6-8C2F-591B6B6275C8

Q27851704-36572A59-D46E-4152-B72B-A9851E61EBD4

Q27851704-37B90591-74C2-4318-82C8-EB4C1175FDE1

Q27851704-49555FAD-5685-47B4-B904-08E9666D3DFB

Q27851704-514983D3-9764-4A52-AD88-4FE8E6BF2044

Q27851704-51C54B97-6A84-4F91-9E73-804E190C68EB

Q27851704-5599947D-8DC2-4343-AF4D-E5E6836D25CB

P304

Q27851704-98EA045B-005B-4DDA-ACE9-C8795A0EA0E3

P31

Q27851704-C04114CA-0230-412C-81FB-77EC82869091

P3181

Q27851704-1D42446B-32E4-47DD-9933-30466A2FB7A4

P356

Q27851704-F320D407-EFAC-4F6F-832D-4FE2FBBD63E2

P407

Q27851704-CA808C12-F9E1-4DB7-9A3F-81556B262468

P433

Q27851704-8BC1D21E-D261-4A3A-A23D-155D6A3E8EF2

P478

Q27851704-4D72FD91-5750-43E5-B510-46EE638B99CC

P50

Q27851704-DC563DC9-3471-4E0B-9F74-335E41204686

P577

Q27851704-E08E2FC7-7DB9-4F7C-A0DA-1C1CEB727795

P5875

Q27851704-8E537DC9-03AA-4DDF-A16F-4BA1E49A3EC2

P698

Q27851704-B0811A9C-FB27-4059-9EEB-85D8C820EC6D

P921

Q27851704-234A38A9-F805-4A88-9B16-79027FFC861E

Q27851704-C4E9ADF2-CF5A-4F4D-B6AE-17035090035C

P3181

P356

P1433

P1476

Identification of anaplastic l ...... tibody-enhanced polymer method

@en

P2093

Emiko Sugawara

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Mano

http://www.w3.org/2001/XMLSchema#string

Junji Yonese

http://www.w3.org/2001/XMLSchema#string

Masanobu Kitagawa

http://www.w3.org/2001/XMLSchema#string

Naoto Kuroda

http://www.w3.org/2001/XMLSchema#string

Reimi Asaka

http://www.w3.org/2001/XMLSchema#string

Satoko Hatano

http://www.w3.org/2001/XMLSchema#string

Seiji Sakata

http://www.w3.org/2001/XMLSchema#string

Takeshi Yuasa

http://www.w3.org/2001/XMLSchema#string

Yuichi Ishikawa

http://www.w3.org/2001/XMLSchema#string

P2860

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues

TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.

Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

Crizotinib in anaplastic large-cell lymphoma.

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum

P304

4427-4436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3098181

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/CNCR.27391

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221754923

http://www.w3.org/2001/XMLSchema#string

P698

22252991

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry